CPH on it's own were likely going to fail long-term. There wasn't much doubt about that (unless management changed which wasn't going to happen).
However now holders may stand a chance with the new Company in their TRIP share holdings.
Probably the most positive (and legitimising) thing is William Lay is joining the team.
Mr. William Lay, previously Associate Director, M&A at Canopy Growth appointed Executive Vice President and Chief Strategy Officer to assist in growth trajectory - Mr. Lay has overseen and/or supported over C$5Bn in cannabis M&A transactions.
But I agree, the sooner they can get EverBlu out of the picture the better. There's a reason they call it conflicts of interest and why it's a huge no-no in business.
CPH Price at posting:
16.8¢ Sentiment: Sell Disclosure: Held